Näky Review

Näky in one line: flat-priced compounded GLP-1s with a microdose track and brand-name pills

Näky is a telehealth brand of Naky Health LLC selling compounded semaglutide and tirzepatide injections, a separate lower-dose microdose program, and two FDA-approved pills, Wegovy and Foundayo. If you want one price that doesn't rise as your dose goes up, and you'd like to see that price before you start, Näky is built for you. If you want a named pharmacy and a named medical group behind your prescription, you'll find less here than at the best-documented providers.

How the pricing works

Each product page lists its plans before intake. Compounded semaglutide is $185 a month (+ added fee) on the 1-month plan and compounded tirzepatide is $295, with lower monthly rates if you prepay: as little as $145 a month for semaglutide and $265 for tirzepatide on a 6-month plan. For context, the typical compounded GLP-1 provider runs around $182 a month, so Näky's month-to-month semaglutide price sits near the middle of the market and only gets cheaper if you commit for longer.

How we get the market median: $182 is the middle value of each program's lowest listed ongoing monthly price for compounded semaglutide (month to month, not a first-month promo, a prepaid plan or a price with a membership on top), across the 122 programs that publish one.

Compounded plans have no membership fee and cost the same at every dose, which means your bill doesn't climb as your provider titrates you up to a therapeutic dose, a common sticker-shock moment at dose-tiered competitors. The brand-name pills work differently. The Wegovy and Foundayo pills are priced by dose, rising as you move up to maintenance, and every FDA-approved plan adds a $125 monthly membership on top.

The medications and how they're dispensed

Näky's lineup has four parts:

• Compounded injections: weekly semaglutide or tirzepatide at one flat price per plan length.
• A GLP-1 microdose program: a separate, lower-dose track for people who want a gentler on-ramp or maintenance approach rather than full therapeutic dosing.
• Brand-name pills: the FDA-approved Wegovy pill (oral semaglutide) and Foundayo pill (orforglipron), for people who would rather take a daily tablet than inject, with a published dose-by-dose price.
• NAD+ and Sermorelin add-ons: for patients who want to build a longevity or recovery stack on top of weight-loss treatment. Nice-to-have rather than core.

Prescribing is handled by an independent physician group, and compounded medication is filled by what Näky describes as licensed partner pharmacies with traceable 503 sourcing, with no specific pharmacy named. Shipping is free, and the site advertises delivery in two days. When not paying until a doctor approves you is your priority, Blue Haven RX holds the charge until a physician signs off and folds the consult into one flat price, but it doesn't name its pharmacies either.

Where Näky differs

Näky's main differentiator is range under one flat-pricing model. Most compounded telehealth brands give you injectable semaglutide and tirzepatide and stop there. Näky adds a microdose program and two brand-name pills, so it can serve cautious starters who want to ease in and needle-averse patients who would rather take an FDA-approved tablet. Onboarding is quick: a free online assessment, then a treatment plan from a licensed provider, with the whole process online.

Where Näky is weak: transparency

Näky now names its operator (Naky Health LLC, with an Aliso Viejo, California address) and posts its prices, but a few things a careful patient should be able to check are still missing:

• No named pharmacy partner: only the generic "licensed partner pharmacies with traceable 503 sourcing" claim, with no specific compounding pharmacy named.
• No named medical group: the site says an independent physician group makes prescribing decisions but doesn't say which one.
• No published state-by-state availability: Näky doesn't list which states it serves, so coverage is unclear until you sign up. Another provider to compare is Gatlan, which names its chief medical advisor and lists the 44 states it serves, but it shows prices only inside sign-up.
• Support by email only: there's no phone number or support hours listed.

None of this is a red flag on its own, and to Näky's credit it displays a LegitScript certification seal, a third-party attestation that the platform meets legitimate-pharmacy standards. There are no FDA warning letters against Näky, either. But an unnamed pharmacy and an unnamed physician group mean you're being asked to trust more on faith than the better-documented providers in our scoring methodology require.

Who should choose Näky, and who should skip it

Choose Näky if you like the flat "same price at every dose" structure, want a microdose protocol, or want a brand-name GLP-1 pill from the same place that sells compounded injections. The posted prices and fast onboarding suit someone who has already compared options.

Skip Näky if you need to confirm your state before sharing health information, if a named, accredited pharmacy is non-negotiable for you, or if you want the lowest month-to-month price without prepaying. Patients who want the full supply chain on the record will be happier with a provider that names its pharmacy.

Bottom line

Näky is a legitimate, LegitScript-certified option with flat pricing on compounded plans, a microdose track and two brand-name pills. Its weak spot is the supply chain: no named pharmacy, no named physician group and no state list. At $185 a month (+ added fee) on the 1-month semaglutide plan it sits near the $182 category benchmark, and the prepaid plans bring it lower. If those gaps don't bother you, run the free assessment and pick the plan length that fits.